Stocks To Watch: Biocon, Indian Oil, Jet Airways, SAIL

Risk appetite returned to markets on Monday, as U.S. equity futures climbed alongside Asian stocks, the Australian dollar and the Chinese yuan, after a truce between Washington and Beijing emerged from the Group-of-20 summit.

S&P 500 Index futures jumped over 1.5 percent, while the Aussie and the currencies of South Africa, Turkey and Mexico all rose. Shares from Sydney to Seoul gained. The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, rose 0.4 percent to 11,000.50 as of 6:50 a.m.

Short on time? Well, then listen to this podcast for a quick summary of All You Need To Know before the opening bell.

Here Are The Stocks To Watch Out For In Today’s Trade

• Biocon’s jointly developed product “Fulphila” with Mylan has been granted marketing authorisation from the European Commission.
• Monte Carlo Fashion’s board approved buy back of 4.6 percent of equity paid-up share capital at Rs 550 per share, aggregating to Rs 55 crore.
• Indian Oil Corporation to reduce Delhi’s non-subsidized LPG price by Rs 133 per bottle from Dec. 01, according to a Bloomberg report.
• SAIL’s Durgapur alloy plant is showing improved performance and the unit is geared up to make profit next year said Steel Minister, Birender Singh. He also added that Durgapur Steel plant is in the process of scaling up crude output from 1.8 million tons now to 2.2 million tons next year and losses at Salem Mill have been reduced this year and may drop by around 20 percent, Bloomberg reported.
• TV Today Network’s Chief Executive Officer Vivek Khanna resigned from his post.
• Aviation stocks in focus as ATF prices for October cut by 11 percent pan India due to lower crude prices and stronger rupee.
• The Uttar Pradesh government state advised prices (SAP) for sugarcane at Rs 315 a quintal.
• Sandhar Technologies signed JV pact with South Korea's Kwangsung to make plastic-mould parts for cars, trucks.

Media Reports

• SEBI to reopen insider trading case against Sun Pharma (PTI).
• NMDC cuts iron order prices by upto 8 percent in December (Mint).
• Sale process of NIIT Tech gathered momentum; Many global local players like Tech Mahindra have been approached (Economic Times).
• Tata Sons rejected acquisition proposal of Prabhat Dairy for Rs 400 crore by Tata Global Beverages (Economic Times).

Offering

• Reliance Mutual Fund managed DPSE ETF FPO raises Rs 27,300 crore against the government’s proposal to raise Rs 8,000 crore from the offering.
• The government will accept Rs 17,000 crore of bids following the over-subscription.

Data To Watch

• Automobile manufacturers will continue reporting their monthly sales data for November.
• Nikkei India Manufacturing PMI for Nov., prior 53.1.

Data Reaction To Watch

• GDP growth drops to 7.1 percent in the second quarter.
• Fiscal deficit reaches 103.9 percent of full year target in October.

November Auto Sales (YoY)

• Maruti Suzuki down 0.7 percent at 1.53 lakh units.
• M&M up 17 percent 45,101 units.
• Escorts up 56 percent at 8,005 units.
• Tata Motors down 4 percent at 50,470 units.
• Hero MotoCorp up 0.8 percent to 6.1 lakh units.

Catch all the live updates of November auto sales here.

Bulk Deals

• Bharat Heavy Electricals: Integrated Core Strategies (Asia) acquired 3.01 crore shares 0.82 percent equity at Rs 68.57 each.
• CARE Ratings: Copthall Mauritius Investment acquired 1.52 lakh shares or 0.52 percent equity at Rs 957.2 each.
• Divi’s Laboratories: Integrated Core Strategies (Asia) sold 18.86 lakh shares or 0.71 percent equity at Rs 1,438.98 each.
• Repco Home Finance: Pabrai Investment Fund sold 6.84 lakh shares or 1.09 percent equity at Rs 338.17 each.

ICICI Lombard General Insurance

• Red Bloom Investment sold 1.3 crore shares or 2.92 percent equity at Rs 800 each.
• RWC Global Emerging Equity Fund acquired 21.9 lakh shares or 0.48 percent equity at Rs 800 each.
• Fidelity Funds Asia Pacific Dividend Fund acquired 19.2 lakh shares or 0.42 percent equity at Rs 800 each.
• DSP MF acquired 15 lakh shares or 0.33 percent equity at Rs 800 each.

Ramkrishna Forgings

• Abakkus Growth Fund acquired 5 lakh shares or 1.53 percent equity at Rs 515 each.
• Old Bridge Capital Management acquired 8 lakh shares or 2.46 percent equity at Rs 515 each.
• Vantage Equity Fund acquired 2.8 lakh shares or 0.86 percent at Rs 516.67 each.
• Amansa Holdings sold 19 lakh shares or 5.24 percent equity at Rs 515.24 each.

Who’s Meeting Whom

• Shriram Transport Finance to meet Matthews Asia, Oppenheimer Fuds and other investors from Dec. 03-17.
• TCS to meet Blackrock, Axis AMC and Capital World Investors from Dec. 05-21.
• Cipla to meet Birla Sun Life Insurance and Stewart Investors from Dec. 03-4.
• Tata Chemicals to meet HDFC MF, Ambit Securities and Aditya Birla Sun Life Insurance from Dec. 03-06.
• Tata Motors to meet Moon Capital, Franklin Capital and other investors from Dec. 03-04.

Insider Trading

• Arvind promoter Aura Business Ventures LLP acquired 1.67 lakh shares from Nov. 28-29.
• Alembic promoter group Nirayu acquired 2.05 lakh shares from Nov. 28-29.
• Astra Microwave Products promoter sold 1 lakh shares on Nov. 28.
• Mahindra Logistics promoter group Partners Enterprise sold 16.22 lakh shares on Nov. 29.

(As reported on Nov. 30)

Trading Tweaks

• Oil India record date for share buyback.
• Rain Industries price band revised to 5 percent.

Money Market Update

• Rupee ended at 69.58/$ on Friday versus 69.84/$ on Thursday. The home currency clocked its biggest monthly gain in almost seven years.

F&O Cues

• Nifty December Futures closed trading at 10900, premium of 23 points.
• Max OI for December series at 11,000 Call, OI at 25.4 lakh shares.
• Max OI for December series at 10,000 Put, OI at 37.8 lakh shares.

Put-Call Ratio

• Nifty PCR at 1.7 from 1.75
• Nifty Bank PCR at 1.17 from 1.33

Brokerage Radar

CLSA on Motherson Sumi

• Maintained ‘Outperform’; cut price target to Rs 180 from Rs 223.
• Indian business in soft patch, but remain positive on outlook.
• Weak European auto demand hurting, but new plant ramp-up to offer a cushion.
• Cut FY19-21 EPS estimates by 7-14 percent; see further downside to consensus estimates.

UBS on Sun Pharma

• Maintained ‘Buy’ with a price target of Rs 690.
• Whistle-blower allegations are valuation dampener at the minimum.
• Negatively impacts Mgmt.’s bandwidth at a time when key brands are getting launched.
• Expect stock to react negatively to the whistle-blower allegations.

Nomura on Glenmark Pharma

• Maintained ‘Buy’; hiked price target to Rs 850 from Rs 825.
• Remain constructive due to strong domestic growth and progress in clinical development .
• Hike 2018-19 EPS estimates by 22 percent to factor in forex and inlicensing income in the first half.
• Catalysts: out-licensing deals, key ANDA approvals and strong India growth.

Nomura on Indian Tyre makers

• Believe industry fundamentals are in better shape now with healthy demand and high utilisation.
• Play on healthy growth outlook, pricing discipline, benign commodity prices to support margins.
• Despite capacity expansion, a strong demand scenario to keep utilisation healthy.
• Apollo Tyres: Initiated ‘Buy’ with a price target of Rs 288.
• CEAT: Initiated ‘Neutral’ with a price target of Rs 1,346.
• Balkrishna Industries: Initiated ‘Neutral’ with a price target of Rs 1,008.